Medical Technology

Report: Update on cell technology, cell therapy, tissue engineering and gene therapy in Japan

About the Report 

This report is an updated edition of a first study on cell technology, cell therapy, tissue engineering and gene therapy in Japan published in 2015. It aims to summarise key events which have taken place in academic and medical research in these different fields. Furthermore, the report includes information concerning Japanese industrial landscapes as well as Japanese Government activities related to these medical advances. Lastly, it provides various recommendations to EU companies for a successful market entry.

30-04-15 to 30-04-15 | 10:30 h - 11:30h

Webinar 41: Cell technology, cell therapy, tissue engineering and gene therapy in Japan

What’s on in Japan regarding cell technology and gene therapy, and are there partnership opportunities?

Japan has managed to establish a highly coordinated national program for cell engineering, not only in R&D, but also for translational activities such as clinical trials, equipment manufacturing and standardization. Still, Japan, as always, is hungry for further innovations. Might it make sense to team up with a pragmatic leader?

Case Study: GA Generic Assays GmbH: a German SME

GA Generic Assays GmbH – from DE

Founded in 2002, GA Generic Assays GmbH is a privately owned company manufacturing and distributing diagnostic test kits focusing on autoimmune diseases.

Medical & Dental Devices

Since FY2014, the Japanese Government is implementing a 5-year long “Healthcare and Medical Strategy” under the principal philosophy of realizing a society with a long healthy life expectancy as well as economic growth through cutting-edge medical technologies and ser

Subscribe to RSS - Medical Technology